2 assistance programs for Lupron Depot patients · 2 open today
Two AbbVie programs cover the gynecology kits: a commercial copay card and a free-drug program for uninsured patients. No foundation fund on file covers endometriosis or fibroids.
Select the patient's insurance to see which programs may apply.
Current status · Award amounts · Eligibility · Direct application links · verified July 16, 2026
Lupron Depot · Endometriosis · Commercial insurance
Eligible patients may pay $10
Example · Lupron Depot · 3.75 mg · 1 units · commercial plan · deductible met · 20% coinsurance · allowed amounts at the Medicare reference rate
| Without assistance | With AbbVie Copay Savings Card | |
|---|---|---|
| Drug responsibility | $359.81 | $10.00 |
| Administration (96372) | $3.07 | $3.07 |
| Patient owes | $362.88 | $13.07 |
Estimated patient savings: $349.81
CareCost calculates the drug and administration lines using the patient’s payer rate and benefits; this example uses the Medicare rate as a reference.
Also available if this patient’s coverage falls short
Free myAbbVie Assist (Free Drug) for eligible patients
Change the diagnosis to see only the programs that apply to your patient.
Lupron Depot shares its class with Fensolvi (J1951, Tolmar), Zoladex (J9202, TerSera), billed under their own codes with their own manufacturer programs. The programs above apply to Lupron Depot only. If the payer requires the other product instead, use that manufacturer’s program below.
No manufacturer program record is on file for Fensolvi or Zoladex; check the maker’s own site before quoting one.
| Task | ✓ |
|---|---|
| Find programs for this insurance type | ✓ |
| See whether each program is open | ✓ |
| See maximum award | ✓ |
| Review key eligibility requirements | ✓ |
| Open the official application | ✓ |
| Calculate cost before assistance | ✓ |
| Apply the program benefit | ✓ |
| Calculate what the patient still owes | ✓ |
Commercial insurance: Eligible commercially insured patients may qualify for the AbbVie Copay Savings Card. Eligible patients may pay as little as $10 per dose, up to $3,600 a year, subject to current program terms; the card covers the drug only, not the 96372 injection fee. View current program ↑
Medicare: Manufacturer copay savings cannot be used when government insurance is paying for Lupron Depot; the federal Anti-Kickback Statute is why, per HHS OIG guidance on copayment coupons. myAbbVie Assist is not a fallback either: it is limited to uninsured patients. No foundation fund on file covers endometriosis or fibroids: Good Days runs a metastatic prostate-cancer fund, HealthWell Foundation runs separate breast-cancer, head-and-neck-cancer, and prostate-cancer funds, and PAN Foundation runs a prostate-cancer fund, five funds in all, none of them gynecologic, and all five are currently closed to new applications. View current options ↑
Uninsured: myAbbVie Assist provides Lupron Depot at no cost to patients at or below 400% of the federal poverty level; it covers the drug only, and administration is billed separately. No foundation fund on file covers endometriosis or fibroids either, since the same five prostate, breast, and head-and-neck cancer funds are the only ones tied to this product, and none accepts a gynecology diagnosis regardless of open or closed status. Check today’s status ↑
Why fund status matters: a program's status is not fixed. It moves between OPEN (accepting applications now), WAITLIST (not enrolling immediately) and CLOSED (not accepting new applications), and every CareCost program card shows the current status along with the date it was verified.
Why the product name matters: Lupron Depot's gynecology kits bill J1950, per 3.75 mg; the same brand's prostate-cancer strengths (7.5, 22.5, 30 and 45 mg) bill J9217, per 7.5 mg, with a different administration code. Lupron Depot-Ped, for central precocious puberty, also bills J1950 but has no separate assistance record on this page. AbbVie's two programs above list eligibility across the whole product line, but the claim itself must match the strength the patient actually received.
Yes. The AbbVie Copay Savings Card is AbbVie’s current manufacturer savings program for the gynecology kits. Eligible commercially insured patients may pay as little as $10, up to $3,600 a year, for the drug only. The injection fee is billed separately. Apply on AbbVie’s savings site ↗ Calculate cost with the program →
No. Patients using Medicare or other government-funded insurance to pay for Lupron Depot are not eligible for the manufacturer’s copay card. myAbbVie Assist is not a fallback either: it is limited to uninsured patients. No foundation fund on file covers endometriosis or fibroids: Good Days runs a metastatic prostate-cancer fund, HealthWell Foundation runs separate breast-cancer, head-and-neck-cancer, and prostate-cancer funds, and PAN Foundation runs a prostate-cancer fund, five funds in all, none of them gynecologic, and all five are currently closed to new applications. Check current options ↑
Yes. A patient with no insurance at all can use myAbbVie Assist, which covers the drug at no cost for households at or below 400% of the federal poverty level; the injection fee still bills separately. Endometriosis and fibroids remain outside the five foundation funds tied to this product (prostate, breast and head-and-neck cancer grants), so none of them is an option for an uninsured gynecology patient regardless of open or closed status. Check today’s status ↑
Data current: programs verified Jul 16, 2026
AbbVie Copay Savings Card · myAbbVie Assist (Free Drug) · Good Days (metastatic prostate cancer) · HealthWell Foundation (breast, head-and-neck, and prostate cancer) · PAN Foundation (prostate cancer). No fund on file covers endometriosis or fibroids. Every program links directly to its official source or application page.
Last program check: .
Reviewed September 20, 2026 by Erin Rose, CareCost Estimate founder. Methodology →
CareCost